Inventor · disambiguated record
Hao Wang
Also filed as: WANG HAO · WANG HAO CHEN
31 granted patents·23 pending applications·33 citations·filing 2006–2025
94Inventor score
Files withBEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD5FMC CORP4MERCK SHARP & DOHME4SCINNOHUB PHARMACEUTICAL CO LTD4APPLIED PHARMACEUTICAL SCIENCE INC3
Top patents by PatentIndex Score
54 records- 0197US12031012B2Antidegradant composition, antidegradant master batch and rubber compositionSENNICS CO LTD·Filed 2021·Granted Jul 9, 2024·2 cites·20 claims
- 0291US9034893B2Process for reducing contaminating michael acceptor levels in oxycodone and other compositionsSHAFER JULES A·Filed 2010·Granted May 19, 2015·9 cites·17 claims
- 0388US7875623B2Process for reducing contaminating Michael acceptor levels in oxycodone and other compositionsCONTROLLED CHEMICALS INC·Filed 2006·Granted Jan 25, 2011·12 cites·25 claims
- 0487US11795200B2Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseasesFUTU BIOTECH CO LTD·Filed 2022·Granted Oct 24, 2023·1 cites·7 claims
- 0585US11655240B1Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseasesBEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD·Filed 2022·Granted May 23, 2023·2 cites·20 claims
- 0683US12338253B2Nitrogen-containing polycyclic fused ring compound, pharmaceutical composition thereof, preparation method therefor and use thereofAPPLIED PHARMACEUTICAL SCIENCE INC·Filed 2020·Granted Jun 24, 2025·2 cites·92 claims
- 0782US11840526B2Compounds and method for preparing the sameBEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD·Filed 2022·Granted Dec 12, 2023·1 cites·19 claims
- 0882US9403838B2Process for reducing contaminating Michael acceptor levels in oxycodone and other compositionsCONTROLLED CHEMICALS INC·Filed 2014·Granted Aug 2, 2016·2 cites·16 claims
- 0968US10749065B2Preparation method and application of light-responsive LED based on GaN/CsPbBrxI3-x heterojunctionUNIV HUBEI·Filed 2019·Granted Aug 18, 2020·2 cites·5 claims
- 1068US2025179043A1Processes for the preparation of n-(1-methylcyclopropyl)-2-(3-pyridinyl)-2h-indazole-4-carboxamide and intermediates thereofFMC CORP·Filed 2023·Application pending·0 cites
- 1166US12297296B2Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseasesFUTU BIOTECH CO LTD·Filed 2022·Granted May 13, 2025·0 cites·8 claims
- 1266US11752128B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Sep 12, 2023·0 cites·3 claims
- 1365US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1464US12304868B2Method for preparing ceramic materials and products thereofUNIV CITY HONG KONG·Filed 2021·Granted May 20, 2025·0 cites·16 claims
- 1564US12031037B2Rubber protective wax, preparation method and application thereofSENNICS CO LTD·Filed 2021·Granted Jul 9, 2024·0 cites·18 claims
- 1663US11738010B2Oxazolidinones as TarO inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Aug 29, 2023·0 cites·14 claims
- 1763US2025250228A1Methods for the preparation of 5-chloro-2-((ethoxycarbonyl)amino)-3-methylbenzoic acidFMC CORP·Filed 2023·Application pending·0 cites
- 1861US12391572B1Preparation method of manganese iron phosphate precursor, cathode sheet, and lithium batteryHUNAN YUNENG NEW ENERGY BATTERY MAT CO LTD·Filed 2025·Granted Aug 19, 2025·0 cites·8 claims
- 1961US2025326713A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2060US10201174B2Process for reducing contaminating Michael acceptor levels in oxycodone and other compositionsCONTROLLED CHEMICALS INC·Filed 2016·Granted Feb 12, 2019·0 cites·17 claims
- 2159US11414411B2Chemical process for manufacturing monobactam antibiotic and intermediates thereofNOVARTIS AG·Filed 2018·Granted Aug 16, 2022·0 cites·17 claims
- 2259US11141410B2Oxazolidinones as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·14 claims
- 2359US2025360145A1Csf-1r inhibitors and uses thereofMYROBALAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2458US2024190873A1Method for preparing phosphodiesterase inhibitorTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 2558US2025066307A1Process for producing high-purity epsilon-caprolactamCHINA PETROLEUM & CHEM CORP·Filed 2022·Application pending·0 cites
- 2657US11918951B2MOF compositions for selective separation of hydrocarbonsUNIV RUTGERS·Filed 2019·Granted Mar 5, 2024·0 cites·20 claims
- 2757US11141403B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·1 claims
- 2857US2024083884A1Compounds and method for preparing the sameBEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD·Filed 2023·Application pending·0 cites
- 2956US2024132462A1Method for preparing tert-butyl n-((1r,2s,5s)-2-((2-((5-chloropyridin-2-yl)amino)-2-oxoacetyl)amino)-5-(dimethylcarbamoyl)cyclohexyl)carbamateFMC CORP·Filed 2022·Application pending·0 cites
- 3056US2023302005A1Active pharmaceutical ingredient, preparation method thereof, and pharmaceutical composition including the sameBEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD·Filed 2023·Application pending·0 cites
- 3155US2023365536A1Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseasesBEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD·Filed 2023·Application pending·0 cites
- 3254US11020727B2Fe43.4Pt52.3Cu4.3 polyhedron nanoparticle with heterogeneous phase structure, preparing method and application thereofUNIV HUBEI·Filed 2019·Granted Jun 1, 2021·0 cites·8 claims
- 3354US2025250283A1Compound capable of regulating and controlling activity of 15-pgdh, and preparation method thereforSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 3453US12109551B2Rare-earth-manganese/cerium-zirconium-based composite compound, method for preparing same and use thereofGRIREM ADVANCED MAT CO LTD·Filed 2020·Granted Oct 8, 2024·0 cites·28 claims
- 3552US12508225B2Lipid compound and use thereof in delivery of nucleic acidBEIJING TRICISIONBIO THERAPEUTICS INC·Filed 2022·Granted Dec 30, 2025·0 cites·7 claims
- 3652US2025154162A1Compound for regulating and controlling 15-pgdh activity and preparation method thereforSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 3751US2024174674A1Nitrogen-containing polycyclic fused ring compound, pharmaceutical composition thereof, preparation method therefor, and use thereofAPPLIED PHARMACEUTICAL SCIENCE INC·Filed 2022·Application pending·0 cites
- 3851US2021087194A1Chemical Process for Preparing Imidazopyrrolidinone Derivatives and Intermediates ThereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3951US2025084100A1Method for preparing nitrogen-containing polycyclic fused ring compound, and intermediate and use of compoundAPPLIED PHARMACEUTICAL SCIENCE INC·Filed 2022·Application pending·0 cites
- 4050US2025178234A1Method of additively manufacturing high-purity silicon, method of additively manufacturing semiconductor manufacturing equipment component, semiconductor manufacturing equipment component, and method of forming semiconductor manufacturing equipment componentTOKYO ELECTRON LTD·Filed 2025·Application pending·0 cites
- 4149US9019602B2Scattering screen system, method of manufacture and application thereofUNIV CITY HONG KONG·Filed 2013·Granted Apr 28, 2015·0 cites·15 claims
- 4249US2023022378A1Methods for the preparation of ethyl 3-bromo-1-(3-chloropyridin-2-yl)-1h-pyrazole-5-carboxylateFMC CORP·Filed 2020·Application pending·0 cites
- 4349US2019337952A1Chemical Process for Preparing Imidazopyrrolidinone Derivatives and Intermediates ThereofNOVARTIS AG·Filed 2017·Application pending·0 cites
- 4449US2024300986A1Plasmin inhibitor, preparation method therefor and application thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4548US2024124443A1Plasmin inhibitor, preparation method therefor, and application thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 4645US9505851B2Antifungal composite and method for manufacturing the sameSU TING-HUNG·Filed 2015·Granted Nov 29, 2016·0 cites·1 claims
- 4745US2021395275A1Compositions and methods for selective separation of hydrocarbon isomersUNIV RUTGERS·Filed 2019·Application pending·0 cites
- 4842US10829497B2Crystal form II of thienopyridine derivative bisulfate and preparation method therefor and use thereofZHONGRONG KAITE BEIJING BIOTECHNOLOGY CO LTD·Filed 2018·Granted Nov 10, 2020·0 cites·11 claims
- 4941US12319687B2Indole alkaloid compound in noni enzyme and preparation method and application thereofUNIV HAINAN NORMAL·Filed 2021·Granted Jun 3, 2025·0 cites·6 claims
- 5041US11220436B2Basic zinc chloride particulate matter and preparation method thereforGUANGZHOU COSMO ENVIRONMENTAL TECH CO LTD·Filed 2017·Granted Jan 11, 2022·0 cites·18 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hao Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →